Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma von van Boxtel, W., Locati, L.D., van Engen-van Grunsven, A.C.H., Bergamini, C., Jonker, M.A., Fiets, E., Cavalieri, S., Tooten, S., Bos, E., Quattrone, P., Verhaegh, G.W., Schalken, J.A., Licitra, L., van Herpen, C.M.L.

Volltext

Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review von Uijen, M.J.M., Lassche, G., van Engen-van Grunsven, A.C.H., Tada, Y., Verhaegh, G.W., Schalken, J.A., Driessen, C.M.L., van Herpen, C.M.L.

Volltext

904P Retrospective analysis of adjuvant systemic anti-hormonal therapy for resected androgen receptor-positive (AR+) salivary duct carcinoma (SDC) von Weijers, J.A.M., Verhaegh, G.W., Driessen, C.M.L., Engen-van Grunsven, I.V., Devriese, L.A., Slingerland, M., Hoeben, A., Schalken, J.A., Van Herpen, C.M.L.

Volltext

Noncoding RNAs as Novel Biomarkers in Prostate Cancer von Schalken, Jack A., Luna-Velez, M. V., Verhaegh, G. W., Rönnau, C. G. H.

Volltext

1169P - Development and characterization of salivary gland cancer organoid cultures von Boxtel, W.V., Aalders, T.M.W., Lassche, G., van Engen - van Grunsven, I.C.H., Verhaegh, G.W., van Herpen, C., Schalken, J.

Volltext

Development and characterization of salivary gland cancer organoid cultures von Boxtel, W.V., Aalders, T.M.W., Lassche, G., van Engen - van Grunsven, I.C.H., Verhaegh, G.W., van Herpen, C., Schalken, J.

Volltext

UP27 - Analysis of extracellular vesicles in urines from prostate cancer patients von Van Royen, M.E., Dits, N.F., Verhaegh, G.W., Van Steijn, V., Bijnsdorp, I.V., Martens-Uzunova, E.S., Jimenez, C.R., Schalken, J.A., Jenster, G.W.

Volltext

Analysis of extracellular vesicles in urines from prostate cancer patients von Van Royen, M.E., Dits, N.F., Verhaegh, G.W., Van Steijn, V., Bijnsdorp, I.V., Martens-Uzunova, E.S., Jimenez, C.R., Schalken, J.A., Jenster, G.W.

Volltext

The androgen-regulated lncRNA NAALADL2-AS2 promotes tumor cell survival in prostate cancer von Groen, L., Boer, S., Smit, F.P., Schuitmaker, W., Yurevitch, V., Baars, J., Chen, J., Steenge, L., Ramu, H., Verhaegh, G.W., Mehra, N., Schalken, J.A.

Volltext

O05 - The role of LncRNA NAALADL2-AS2 in the development of castration resistant prostate cancer von Groen, L.N., Boer, S., Smit, F.P., Schuitmaker, W., Yurevitch, V., Baars, J., Chen, J., Steenge, L., Ramu, H., Verhaegh, G.W., Mehra, N., Schalken, J.A.

Volltext

The role of LncRNA NAALADL2-AS2 in the development of castration resistant prostate cancer von Groen, L.N., Boer, S., Smit, F.P., Schuitmaker, W., Yurevitch, V., Baars, J., Chen, J., Steenge, L., Ramu, H., Verhaegh, G.W., Mehra, N., Schalken, J.A.

Volltext

246 The castration-resistant prostate cancer-associated miRNAs, miR-3687 and miR-4417, are involved in tumour cell hypoxia response and tumour cell migration von Fussek, S, Rönnau, C, Span, P.N, Burchardt, M, Verhaegh, G.W, Schalken, J.A

Volltext

303 The expression and function of FAM110A in human prostate cancer von Tsuruta, H, Verhaegh, G.W, Schalken, J.A

Volltext

239 AKR1C3 – a potential marker and therapeutic target in castration resistance prostate cancer von Hamid, A.R.A.H, Pfeiffer, M.F, Dudek, A, Völler, M, Verhaegh, G.W, Smit, F.P, Sedelaar, M, Schalken, J.A

Volltext

An association study of germline variants in bladder cancer-related genes with the prognosis of on-Muscle Invasive Bladder Cancer von Hof, J.P, Vermeulen, S.H, van der Heijden, A.G, Verhaegh, G.W, Dyrskjøt, L, Catto, J.W.F, Mengual, L, Bryan, R.T, Fleshner, N.E, Kiemeney, L.A.L.M, Galesloot, T.E

Volltext bestellen

DETECTION OF TMPRSS2-ERG FUSION TRANSCRIPTS AND PCA3 IN URINARY SEDIMENTS MAY IMPROVE DIAGNOSIS OF PROSTATE CANCER von Hessels, D, Smit, F.P, Verhaegh, G.W, Witjes, J.A, Schalken, J.A, Cornel, E.B

Volltext

Hormonale en reproductieve factoren in de ontwikkeling van blaaskanker von Egbers, L., Vermeulen, S.H., Kiemeney, L.A.L.M., Verhaegh, G.W.

Volltext

29 De toegevoegde waarde van de PCA3-urinetest bij prostaatkankerscreening middels PSA bij mannen met een BRCAmutatie von Cremers, R.G.H.M., Ringelberg-Borsboom, J., Vasen, H.F.A., van Asperen, C.J., Schalken, J.A., Verhaegh, G.W., Kiemeney, L.A.L.M.

Volltext

P-47 - The chemotherapeutic drug-sensitizing microRNA, miR-520f, enhances the cisplatininduced cell cycle arrest von de Weijert, M.C.A., Van Kampen, J.G.M., Nikolakopoulou, K., Smit, F.P., Schultz, I., Janicot, M., Schaapveld, R.Q.J., Schalken, J.A., Verhaegh, G.W.

Volltext

The chemotherapeutic drug-sensitizing microRNA, miR-520f, enhances the cisplatininduced cell cycle arrest von de Weijert, M.C.A., Van Kampen, J.G.M., Nikolakopoulou, K., Smit, F.P., Schultz, I., Janicot, M., Schaapveld, R.Q.J., Schalken, J.A., Verhaegh, G.W.

Volltext